SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-036913
Filing Date
2014-11-20
Accepted
2014-11-20 09:16:11
Documents
1
Period of Report
2014-11-18

Document Format Files

Seq Description Document Type Size
1 rrd419170.html 4  
1 rrd419170.xml 4 5032
  Complete submission text file 0001181431-14-036913.txt   6410
Mailing Address C/O BANKAMERICA VENTURES 950 TOWER LANE STE 700 FOSTER CITY CA 94404
Business Address
BOCK LOUIS C (Reporting) CIK: 0001279735 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 141237669

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences